BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 23250116)

  • 21. Changes in vaginal bacterial concentrations with intravaginal metronidazole therapy for bacterial vaginosis as assessed by quantitative PCR.
    Fredricks DN; Fiedler TL; Thomas KK; Mitchell CM; Marrazzo JM
    J Clin Microbiol; 2009 Mar; 47(3):721-6. PubMed ID: 19144794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis.
    Plummer EL; Vodstrcil LA; Doyle M; Danielewski JA; Murray GL; Fehler G; Fairley CK; Bulach DM; Garland SM; Chow EPF; Hocking JS; Bradshaw CS
    mBio; 2021 Oct; 12(5):e0232321. PubMed ID: 34663095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the vaginal microbiota among sexual risk behavior groups of women with bacterial vaginosis.
    Muzny CA; Sunesara IR; Kumar R; Mena LA; Griswold ME; Martin DH; Lefkowitz EJ; Schwebke JR; Swiatlo E
    PLoS One; 2013; 8(11):e80254. PubMed ID: 24236175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Orally administrated
    Qi F; Fan S; Fang C; Ge L; Lyu J; Huang Z; Zhao S; Zou Y; Huang L; Liu X; Liang Y; Zhang Y; Zhong Y; Zhang H; Xiao L; Zhang X
    Front Immunol; 2023; 14():1125239. PubMed ID: 37575226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of Periodic Presumptive Treatment for Bacterial Vaginosis on the Vaginal Microbiome among Women Participating in the Preventing Vaginal Infections Trial.
    Balkus JE; Srinivasan S; Anzala O; Kimani J; Andac C; Schwebke J; Fredricks DN; McClelland RS
    J Infect Dis; 2017 Mar; 215(5):723-731. PubMed ID: 28007924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The vaginal microbiota in the course of bacterial vaginosis treatment.
    Zwittink RD; van den Munckhof EHA; Leverstein-van Hall MA; Boers K; Molijn A; Knetsch CW; Kuijper EJ
    Eur J Clin Microbiol Infect Dis; 2021 Mar; 40(3):651-656. PubMed ID: 33029765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing the regulatory framework in South Africa - a single-blind randomized pilot trial of commercial probiotic supplementation to standard therapy in women with bacterial vaginosis.
    Happel AU; Singh R; Mitchev N; Mlisana K; Jaspan HB; Barnabas SL; Passmore JS
    BMC Infect Dis; 2020 Jul; 20(1):491. PubMed ID: 32650729
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.
    Lee CY; Cheu RK; Lemke MM; Gustin AT; France MT; Hampel B; Thurman AR; Doncel GF; Ravel J; Klatt NR; Arnold KB
    Nat Commun; 2020 Dec; 11(1):6147. PubMed ID: 33262350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing the effect of sucrose gel and metronidazole gel in treatment of clinical symptoms of bacterial vaginosis: a randomized controlled trial.
    Khazaeian S; Navidian A; Navabi-Rigi SD; Araban M; Mojab F; Khazaeian S
    Trials; 2018 Oct; 19(1):585. PubMed ID: 30367673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to Antibiotic Treatment of Bacterial Vaginosis Predicts the Effectiveness of LACTIN-V (Lactobacillus crispatus CTV-05) in the Prevention of Recurrent Disease.
    Hemmerling A; Wierzbicki MR; Armstrong E; Cohen CR
    Sex Transm Dis; 2024 Jun; 51(6):437-440. PubMed ID: 38733973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
    Plummer EL; Bradshaw CS; Doyle M; Fairley CK; Murray GL; Bateson D; Masson L; Slifirski J; Tachedjian G; Vodstrcil LA
    PLoS One; 2021; 16(2):e0246953. PubMed ID: 33571286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bacterial vaginosis: a review on clinical trials with probiotics.
    Mastromarino P; Vitali B; Mosca L
    New Microbiol; 2013 Jul; 36(3):229-38. PubMed ID: 23912864
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis.
    Deng ZL; Gottschick C; Bhuju S; Masur C; Abels C; Wagner-Döbler I
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
    Bradshaw CS; Pirotta M; De Guingand D; Hocking JS; Morton AN; Garland SM; Fehler G; Morrow A; Walker S; Vodstrcil LA; Fairley CK
    PLoS One; 2012; 7(4):e34540. PubMed ID: 22509319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a microarray-based tool to characterize vaginal bacterial fluctuations and application to a novel antibiotic treatment for bacterial vaginosis.
    Cruciani F; Biagi E; Severgnini M; Consolandi C; Calanni F; Donders G; Brigidi P; Vitali B
    Antimicrob Agents Chemother; 2015 May; 59(5):2825-34. PubMed ID: 25733514
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in the vaginal microenvironment with metronidazole treatment for bacterial vaginosis in early pregnancy.
    Mitchell C; Balkus J; Agnew K; Lawler R; Hitti J
    J Womens Health (Larchmt); 2009 Nov; 18(11):1817-24. PubMed ID: 19951217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diversity of cervicovaginal microbiota associated with female lower genital tract infections.
    Ling Z; Liu X; Chen X; Zhu H; Nelson KE; Xia Y; Li L; Xiang C
    Microb Ecol; 2011 Apr; 61(3):704-14. PubMed ID: 21287345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment considerations for bacterial vaginosis and the risk of recurrence.
    Chen JY; Tian H; Beigi RH
    J Womens Health (Larchmt); 2009 Dec; 18(12):1997-2004. PubMed ID: 20044862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vaginal & gut microbiota diversity in pregnant women with bacterial vaginosis & effect of oral probiotics: An exploratory study.
    Vasundhara D; Raju VN; Hemalatha R; Nagpal R; Kumar M
    Indian J Med Res; 2021 Apr; 153(4):492-502. PubMed ID: 34380796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Correlation Analysis of Vaginal Microbiome Changes and Bacterial Vaginosis Plus Vulvovaginal Candidiasis Mixed Vaginitis Prognosis.
    Xiao B; A D; Qin H; Mi L; Zhang D
    Front Cell Infect Microbiol; 2022; 12():860589. PubMed ID: 35372135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.